# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-26-067711
Filing Date
2026-06-11
Accepted
2026-06-11 12:43:58
Documents
51
Period of Report
2026-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | ea0294448-8k_adial.htm iXBRL | 8-K | 130605
2 | AGREEMENT AND PLAN OF MERGER, DATED JUNE 11, BY AND AMONG ADIAL PHARMACEUTICALS, | ea029444801ex2-1.htm | EX-2.1 | 889274
3 | CERTIFICATE OF DESIGNATION OF SERIES A NON-VOTING CONVERTIBLE PREFERRED STOCK, D | ea029444801ex3-1.htm | EX-3.1 | 103835
4 | FORM OF PRE-FUNDED WARRANT (FINANCING) | ea029444801ex4-1.htm | EX-4.1 | 93024
5 | FORM OF WARRANT (FINANCING) | ea029444801ex4-2.htm | EX-4.2 | 93276
6 | FORM OF PRE-FUNDED WARRANT (NOTE EXCHANGE) | ea029444801ex4-3.htm | EX-4.3 | 93023
7 | FORM OF WARRANT (NOTE EXCHANGE) | ea029444801ex4-4.htm | EX-4.4 | 93358
8 | FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF JUNE 11, 2026, BY AND AMONG A | ea029444801ex10-1.htm | EX-10.1 | 263468
9 | FORM OF EXCHANGE AGREEMENT, DATED AS OF JUNE 11, 2026, BY AND AMONG ADIAL PHARMA | ea029444801ex10-2.htm | EX-10.2 | 243405
10 | FORM OF REGISTRATION RIGHTS AGREEMENT, BY AND AMONG ADIAL PHARMACEUTICALS, INC. | ea029444801ex10-3.htm | EX-10.3 | 150190
11 | AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT BETWEEN ADIAL PHARMACEUTI | ea029444801ex10-4.htm | EX-10.4 | 17767
12 | AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN ADIAL PHARMACEUTICALS, INC. AND TONY G | ea029444801ex10-5.htm | EX-10.5 | 18064
13 | AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN ADIAL PHARMACEUTICALS, INC. AND VINAY | ea029444801ex10-6.htm | EX-10.6 | 18197
14 | PRESS RELEASE ISSUED ON JUNE 11, 2026 | ea029444801ex99-1.htm | EX-99.1 | 25402
15 | INVESTOR PRESENTATION, DATED JUNE 2026 | ea029444801ex99-2.htm | EX-99.2 | 41566
16 | GRAPHIC | ea029444801_ex99-2img1.jpg | GRAPHIC | 550615
17 | GRAPHIC | ea029444801_ex99-2img2.jpg | GRAPHIC | 807284
18 | GRAPHIC | ea029444801_ex99-2img3.jpg | GRAPHIC | 503937
19 | GRAPHIC | ea029444801_ex99-2img4.jpg | GRAPHIC | 491138
20 | GRAPHIC | ea029444801_ex99-2img5.jpg | GRAPHIC | 420914
21 | GRAPHIC | ea029444801_ex99-2img6.jpg | GRAPHIC | 615901
22 | GRAPHIC | ea029444801_ex99-2img7.jpg | GRAPHIC | 619524
23 | GRAPHIC | ea029444801_ex99-2img8.jpg | GRAPHIC | 441173
24 | GRAPHIC | ea029444801_ex99-2img9.jpg | GRAPHIC | 523766
25 | GRAPHIC | ea029444801_ex99-2img10.jpg | GRAPHIC | 769371
26 | GRAPHIC | ea029444801_ex99-2img11.jpg | GRAPHIC | 502291
27 | GRAPHIC | ea029444801_ex99-2img12.jpg | GRAPHIC | 426108
28 | GRAPHIC | ea029444801_ex99-2img13.jpg | GRAPHIC | 546043
29 | GRAPHIC | ea029444801_ex99-2img14.jpg | GRAPHIC | 538943
30 | GRAPHIC | ea029444801_ex99-2img15.jpg | GRAPHIC | 344129
31 | GRAPHIC | ea029444801_ex99-2img16.jpg | GRAPHIC | 787427
32 | GRAPHIC | ea029444801_ex99-2img17.jpg | GRAPHIC | 418940
33 | GRAPHIC | ea029444801_ex99-2img18.jpg | GRAPHIC | 385320
34 | GRAPHIC | ea029444801_ex99-2img19.jpg | GRAPHIC | 597292
35 | GRAPHIC | ea029444801_ex99-2img20.jpg | GRAPHIC | 590326
36 | GRAPHIC | ea029444801_ex99-2img21.jpg | GRAPHIC | 382373
37 | GRAPHIC | ea029444801_ex99-2img22.jpg | GRAPHIC | 491135
38 | GRAPHIC | ea029444801_ex99-2img23.jpg | GRAPHIC | 452482
39 | GRAPHIC | ea029444801_ex99-2img24.jpg | GRAPHIC | 376550
40 | GRAPHIC | ea029444801_ex99-2img25.jpg | GRAPHIC | 341567
41 | GRAPHIC | ea029444801_ex99-2img26.jpg | GRAPHIC | 472751
| Complete submission text file | 0001213900-26-067711.txt |  | 21465965

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
42 | XBRL SCHEMA FILE | adil-20260611.xsd | EX-101.SCH | 3005
43 | XBRL LABEL FILE | adil-20260611_lab.xml | EX-101.LAB | 34239
44 | XBRL PRESENTATION FILE | adil-20260611_pre.xml | EX-101.PRE | 22352
54 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0294448-8k_adial_htm.xml | XML | 3306

Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

EIN.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 261082315
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)